Document is current
Any future updates will be listed below
-
Authors
Kitazawa, Shoko https://orcid.org/0000-0002-4934-6622
Chiyoda, Tatsuyuki https://orcid.org/0000-0002-8214-2242
Nakamura, Kohei https://orcid.org/0000-0002-5162-7132
Sakai, Kensuke https://orcid.org/0000-0002-1406-086X
Yoshihama, Tomoko https://orcid.org/0000-0003-4466-0820
Nishio, Hiroshi https://orcid.org/0000-0002-4938-416X
Kobayashi, Yusuke https://orcid.org/0000-0002-4503-2845
Iwata, Takashi https://orcid.org/0000-0001-7846-9261
Banno, Kouji https://orcid.org/0000-0003-2610-2833
Yamagami, Wataru https://orcid.org/0000-0003-3925-6057
Nishihara, Hiroshi https://orcid.org/0000-0002-5460-8703
Aoki, Daisuke https://orcid.org/0000-0002-9596-8326
-
Funding
Funding for this research was provided by:
Japan Society for the Promotion of Science London (21H03079, 21K16822)
- License Information
-
More Information
Article History
Received: 26 April 2023
Accepted: 29 July 2023
First Online: 13 August 2023
Declarations
:
: Tatsuyuki Chiyoda reported grants from Takeda Pharmaceutical Company. Daisuke Aoki reported honoraria from Takeda Pharmaceutical Company, Chugai Pharmaceutical Company, AstraZeneca, MSD and Myriad Genetics. The other authors declare no conflicts of interest regarding this study.
